Oncologists Likely to Get Small Medicare Increases

Publication
Article
OncologyONCOLOGY Vol 13 No 9
Volume 13
Issue 9

Anyone who remembers the bruising political battle in 1997-1998over how Medicare would develop “resource-based” practice expenses can breathe a sign of relief over what is likely to be the painless shift to resource-based malpractice

Anyone who remembers the bruising political battle in 1997-1998over how Medicare would develop “resource-based” practice expenses can breathe a sign of relief over what is likely to be the painless shift to resource-based malpractice expenses. Medicare will work them into its payment formula starting January 1, 2000. That formula takes into account three relative value units (RVUs): for work (accounts for 54.5% of the total payment), practice expense (42.3%), and malpractice expense (3.2%). These three RVUs are added together and then multiplied by a conversion factor of $34.73. The fact that malpractice expenses are such a small part of the formula explains why payment for hematology/oncology codes will increase only 0.3 in 2000, which is fairly typical for most specialties. Medicare also wants to refine some of its practice expense RVUs. That would give hematology/oncology a 1% increase in 2002 over what payments would have been otherwise.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content